Cardiol Res
April 2022
Background: Diffuse long coronary lesions are difficult to treat percutaneously. The aim of the present study was to assess the procedural safety and long-term efficacy of the ultra-long (48-mm) drug-eluting stent Xience Xpedition.
Methods: This was an investigator-initiated, observational, all-comers study.